QUALIGEN THERAPEUTICS INC (QLGN)

US74754R2022 - Common Stock

0.2905  -0.01 (-2.19%)

After market: 0.307 +0.02 (+5.68%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.004.98M5.65M2.85M0.00
Minority Interest Expense
N/A2.39MN/AN/AN/A
Cost Of Goods
N/A4.30M4.33M2.64MN/A
Gross Profit
N/A680.00K1.32M210.00KN/A
Operating Expenses
11.30M18.62M23.99M10.73M10.84M
Research and Development
5.21M6.84M11.72M3.32M6.13M
Selling, General, and Administrative Expenses
6.10M11.79M12.27M7.41M4.57M
Operating Income
-11.30M-17.94M-22.66M-10.52M-10.84M
Interest Income/Expense
-1.52M-30.00K40.00K-50.00K120.00K
Other Income/Expense
2.07M910.00K4.73M-8.05M590.00K
Non Recurring Items
-1.70M-4.24MN/A-920.00KN/A
Income Before Taxes
-12.48M-21.30M-17.89M-19.55M-10.13M
Income Tax
-4.79K-270.00K10.00K0.00N/A
Net Income
-13.42M-18.64M-17.90M-19.55M-10.13M
EBITDA
-11.30M-17.79M-22.55M-10.43M-10.83M
 
Per Share Data
EPS Diluted Total Ops
-2.64-4.85-6.10-11.23-253.25
Non GAAP EPS
N/AN/A-6.10N/A-289.50
 
Statistics
Gross Profit Margin
N/A13.65%23.36%7.37%N/A
Profit Margin
N/A-374.30%-316.81%-685.96%N/A
Operating Profit Margin
N/A-360.24%-401.06%-369.12%N/A

All data in USD

Charts